412 related articles for article (PubMed ID: 31185596)
21. [Monoclonal gammopathy of undetermined significance and multiple myeloma].
Schmalzing M; Tony HP; Knop S
Z Rheumatol; 2017 Oct; 76(Suppl 2):33-37. PubMed ID: 29330758
[TBL] [Abstract][Full Text] [Related]
22. Multiparameter immunophenotyping by flow cytometry as a diagnostic tool in multiple myeloma and monoclonal gammopathy of undetermined significance.
Carulli G; Ottaviano V; Cannizzo E; Giuntini S; Manetti C; Ciancia EM; Azzarà A
Clin Ter; 2012; 163(5):387-92. PubMed ID: 23099966
[TBL] [Abstract][Full Text] [Related]
23. [Unexpected symptoms of monoclonal gammopathy].
Smit PM; Abrahams AC; Schutgens RGE; Notermans NC; Minnema MC
Ned Tijdschr Geneeskd; 2017; 161():D1741. PubMed ID: 29027517
[TBL] [Abstract][Full Text] [Related]
24. Prior autoimmune disease and risk of monoclonal gammopathy of undetermined significance and multiple myeloma: a systematic review.
McShane CM; Murray LJ; Landgren O; O'Rorke MA; Korde N; Kunzmann AT; Ismail MR; Anderson LA
Cancer Epidemiol Biomarkers Prev; 2014 Feb; 23(2):332-42. PubMed ID: 24451437
[TBL] [Abstract][Full Text] [Related]
25. Role of flow cytometry of peripheral blood and bone marrow aspirates in early myeloma.
Yuan CM; Stetler-Stevenson M
Semin Hematol; 2011 Jan; 48(1):32-8. PubMed ID: 21232656
[TBL] [Abstract][Full Text] [Related]
26. Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.
Naina HV; Harris S; Dispenzieri A; Cosio FG; Habermann TM; Stegall MD; Dean PG; Prieto M; Kyle RA; Rajkumar SV; Leung N
Am J Nephrol; 2012; 35(4):365-71. PubMed ID: 22473253
[TBL] [Abstract][Full Text] [Related]
27. A case series of autoimmune diseases accompanied by incidentally diagnosed monoclonal gammopathy: is there a link between the two diseases?
Cho SY; Yang HS; Jeon YL; You E; Lee HJ; Yoon HJ; Park TS
Int J Rheum Dis; 2014 Jul; 17(6):635-9. PubMed ID: 24460798
[TBL] [Abstract][Full Text] [Related]
28. Platelet hyperactivation in multiple myeloma is also evident in patients with premalignant monoclonal gammopathy of undetermined significance.
O'Sullivan LR; Meade-Murphy G; Gilligan OM; Mykytiv V; Young PW; Cahill MR
Br J Haematol; 2021 Jan; 192(2):322-332. PubMed ID: 32478420
[TBL] [Abstract][Full Text] [Related]
29. Secondary monoclonal gammopathy of undetermined significance is frequently associated with high response rate and superior survival in patients with plasma cell dyscrasias.
Zou D; An G; Zhu G; Wang J; Shi L; Meng H; Xu Y; Sui W; Deng S; Zhan F; Qiu L
Biol Blood Marrow Transplant; 2014 Mar; 20(3):319-25. PubMed ID: 24296491
[TBL] [Abstract][Full Text] [Related]
30. Lymphocyte profiles in multiple myeloma and monoclonal gammopathy of undetermined significance: flow-cytometric characterization and analysis in a two-dimensional correlation biplot.
Van den Hove LE; Meeus P; Derom A; Demuynck H; Verhoef GE; Vandenberghe P; Boogaerts MA
Ann Hematol; 1998 Jun; 76(6):249-56. PubMed ID: 9692812
[TBL] [Abstract][Full Text] [Related]
31. Detection of anti-histone activity in sera of patients with monoclonal gammopathies.
Shoenfeld Y; el-Roeiy A; Ben-Yehuda O; Pick AI
Clin Immunol Immunopathol; 1987 Feb; 42(2):250-8. PubMed ID: 3100119
[TBL] [Abstract][Full Text] [Related]
32. Regulation of immunoglobulin synthesis by lymphocytes in multiple myeloma and benign monoclonal gammopathy.
Takeshita A
Nihon Ketsueki Gakkai Zasshi; 1986 Sep; 49(6):1195-205. PubMed ID: 3492847
[No Abstract] [Full Text] [Related]
33. Natural killer cell frequency and serum cytokine levels in monoclonal gammopathies: correlation of bone marrow granular lymphocytes to prognosis.
Sawanobori M; Suzuki K; Nakagawa Y; Inoue Y; Utsuyama M; Hirokawa K
Acta Haematol; 1997; 98(3):150-4. PubMed ID: 9352746
[TBL] [Abstract][Full Text] [Related]
34. [Conduct in case of monoclonal gammapathy ?].
Decaux O
Rev Prat; 2018 Sep; 68(7):777-784. PubMed ID: 30869332
[TBL] [Abstract][Full Text] [Related]
35. Role of cytokines in the pathogenesis of monoclonal gammopathies.
Lust JA
Mayo Clin Proc; 1994 Jul; 69(7):691-7. PubMed ID: 8015336
[TBL] [Abstract][Full Text] [Related]
36. Multiple myeloma and multiple plasmacytomas associated with free gamma heavy chain, free kappa light chain and IgGk paraproteins: an unusual triple gammopathy.
Deighan WI; O'Kane MJ; McNicholl FP; Keren DF
Ann Clin Biochem; 2016 Nov; 53(6):706-711. PubMed ID: 27166317
[TBL] [Abstract][Full Text] [Related]
37. MGUS to myeloma: a mysterious gammopathy of underexplored significance.
Dhodapkar MV
Blood; 2016 Dec; 128(23):2599-2606. PubMed ID: 27737890
[TBL] [Abstract][Full Text] [Related]
38. [Analysis of 128 cases of multiple myeloma and 31 cases of monoclonal gammapathies of undetermined significance].
Zhu JZ; Kuo TT; Wang HR
Zhonghua Nei Ke Za Zhi; 1989 Aug; 28(8):463-5, 508. PubMed ID: 2598728
[TBL] [Abstract][Full Text] [Related]
39. [Subsets of T cells in myeloma, macroglobulinemia and benign monoclonal gammopathy: analysis of surface markers defined by monoclonal antibodies and the effect on Ig-synthesis by B cells].
Okagawa K; Iguchi K; Iishi Y; Kosaka M
Nihon Ketsueki Gakkai Zasshi; 1985 Aug; 48(5):1205-13. PubMed ID: 3934898
[No Abstract] [Full Text] [Related]
40. Plasma Thrombin Generation and Sensitivity to Activated Protein C Among Patients With Myeloma and Monoclonal Gammopathy of Undetermined Significance.
Crowley MP; Kevane B; O'Shea SI; Quinn S; Egan K; Gilligan OM; Ní Áinle F
Clin Appl Thromb Hemost; 2016 Sep; 22(6):554-62. PubMed ID: 26759370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
